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Human herpesvirus type 8 (HHV-8)
Capsid
Capsid protein interactions
Small capsid protein (SCP/ORF65)A systematic investigation of interactions amongst KSHV capsid proteins was undertaken in this study to
comprehend lesser known KSHV capsid assembly mechanisms. Interestingly the interaction patterns of the
KSHV small capsid protein, ORF65 suggested its plausible role in viral capsid assembly pathways. Towards
further understanding this, ORF65-null recombinant mutants (BAC-Δ65 and BAC-stop65) employing a
bacterial artiﬁcial chromosome (BAC) system were generated. No signiﬁcant difference was found in both
overall viral gene expression and lytic DNA replication between stablemonolayers of 293T-BAC36 (wild-type)
and 293T-BAC-ORF65-null upon induction with 12-O-tetradecanoylphorbol-13-acetate, though the latter
released 30-fold fewer virions to themedium than 293T-BAC36 cells. Sedimentation proﬁles of capsid proteins
of ORF65-null recombinant mutants were non-reﬂective of their organization into the KSHV capsids and were
also undetectable in cytoplasmic extracts compared to noticeable levels in nuclear extracts. These observations
collectively suggested the pivotal role of ORF65 in the KSHV capsid assembly processes.lsevier Inc.© 2010 Published by Elsevier Inc.Introduction
Kaposi's sarcoma-associated herpesvirus (KSHV) also designated
as the human herpesvirus 8 (HHV-8), is a DNA tumor virus,
etiologically associated with the AIDS-linked endothelial neoplasm,
Kaposi's sarcoma (KS) (Chang et al., 1994) and several lymphopro-
liferating malignancies (Cesarman et al., 1995; Soulier et al., 1995).
Similar to other herpesviruses, KSHV has a double-stranded (ds) DNA
genome enclosed within a capsid shell, surrounded by a thick,
proteinaceous tegument layer and an outer lipid bilayered envelope
(Liu and Zhou, 2007; Rixon, 1993; Steven and Spear, 1997). The KSHV
capsid is a T=16 icosahedron, constituted by 12 pentons forming the
vertices, 150 hexonsmaking up the faces and edges, and 320 triplexes
interconnecting the pentons and hexons (Rixon, 1993; Steven and
Spear, 1997; Trus et al., 2001; Wu et al., 2000).
Of the structural proteins that constitute the KSHV capsid, the
major capsid protein (MCP/ORF25) constitutes the bulk of it making
up 11 pentons and all the hexons (Nealon et al., 2001; Trus et al.,
2001). Triplexes that ensure stability of the capsid structures are
hetero-trimeric complexes, each of which has one copy of the
triplex-1 protein (TRI-1/ORF62) coupled with two copies of the
triplex-2 protein (TRI-2/ORF26) (Trus et al., 2001; Wu et al., 2000).
The small capsid protein (SCP/ORF65), also designated the smallcapsomer-interacting protein (SCIP), associated with the MCP
exclusively in the hexons (Lo et al., 2003). Additionally during the
early stages of the viral capsid assembly, the inner capsid space is
occupied with both the scaffolding protein, ORF17.5 (SCAF) and the
viral protease (ORF17) (Deng et al., 2008).More recently, approaches
employing cryo-electron tomography (cryo-ET) have identiﬁed a
unique vertex located at the 12th penton of the KSHV capsid
constituting the portal complex comprised of the KSHV PORT protein
(Deng et al., 2007).
Viral capsid assembly and maturation pathways have been exten-
sively studied in related herpesviruses including herpes simplex virus-1
(HSV-1) and human cytomegalovirus (HCMV) (Beaudet-Miller et al.,
1996; Desai and Person, 1996; Newcomb et al., 1996; Rixon, 1993;
Steven and Spear, 1997; Thomsen et al., 1995). Accordingly the viral
capsid assembly gets initiated through the interaction of the portal
complex with the MCP, which in turn interacts with the scaffolding
protein (SCAF) (Newcomb et al., 1996; Thomsen et al., 1995; Zhou et al.,
1998). In addition to bringing together many MCP molecules that build
up the capsomere subunits (hexons and pentons), SCAF also ensures
buildup of the proper curvature and size of the herpesviral capsid
(Newcomb et al., 2001; Saad et al., 1999; Zhou et al., 1998).
Heterotrimers of the triplex proteins, subsequently interconnect the
capsomeres stabilizing the capsid shell (Saad et al., 1999), leading to the
formation of spherical procapsids, which undergo spontaneous angu-
larization forming the icosahedral capsid structures (Newcomb et al.,
1996,2000; Saad et al., 1999; Trus et al., 1996). Degradation and exit of
Table 1














+ + − + −
ORF25 (MCP) + − + + +
ORF26 (TRI-2) − + + + +
ORF62 (TRI-1) + + + − +
ORF65 (SCP) + + + + −
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accompanied with entry of viral DNA through the portal complex (that
occupies the 12th penton) forming the fully mature functional capsid
(Homa and Brown, 1997; Rixon, 1993; Steven and Spear, 1997). From
these well documented observations, it becomes evident that in
herpesviruses, capsid assembly pathways are constituted by dynamic
interactions amongst the viral capsid proteins. Hence it is not surprising
that such interactionshave beenstudied indetail by a plethora of studies
in both HSV-1 (Desai and Person, 1996; Hong et al., 1996; Lee et al.,
2008; Rixon et al., 1996; Saad et al., 1999; Zhou et al., 1998) and HCMV
(Beaudet-Miller et al., 1996; Lai and Britt, 2003).
A systematic dissection of capsid protein interactions in KSHV has
not been undertaken though a study by Uetz et al. (2006) has
provided for a comprehensive picture of the entire KSHV virion
protein interaction network. An earlier study from our laboratory
investigating pair wise interactions between the KSHV viral tegument
proteins, in fact revealed viral tegument assembly processes to be
driven by speciﬁc protein–protein interactions (Rozen et al., 2008).
We hence thought that similar studies amongst KSHV capsid proteins
would help to throw the much needed light on both the viral capsid
architecture and its assembly processes, especially given that
plausible capsid assembly pathways in KSHV are only recently
emerging (Deng et al., 2008). A systematic approach to analyze
interactions between individual KSHV capsid proteins undertaken by
us in this study, led to the generation of a capsid-wide protein
interaction map.
A majority of the interactions corroborated ﬁndings in both
alpha (HSV-1) (Desai and Person, 1996; Hong et al., 1996; Lee et al.,
2008; Rixon et al., 1996; Saad et al., 1999; Zhou et al., 1998) and
beta (HCMV) (Beaudet-Miller et al., 1996; Lai and Britt, 2003)
herpesviruses, including the interaction patterns of ORF65 (SCP)
(Desai et al., 2003; Lai and Britt, 2003; Rixon et al., 1996). This
protein was found to interact with ORF25 (MCP) and with both the
triplex proteins, ORFs 62 and 26, suggesting a probable role of this
protein in KSHV capsid assembly. Interestingly compared to the
other KSHV capsid proteins, ORF65 is the least conserved among its
homologs in both HSV-1 and HCMV with respect to both its amino
acid sequence and size (Nealon et al., 2001; Trus et al., 2001; Wood
et al., 1997; Wu et al., 2000), with KSHV ORF65 being the largest in
size. Based on this, it has been suggested that the SCPs among the
different subgroups of herpesviruses could have different binding
properties and diverse functional roles, as documented in earlier
studies (Borst et al., 2001; Tatman et al., 1994; Thomsen et al.,
1994). Though omission of the HSV-1 SCP did not affect both capsid
assembly (Tatman et al., 1994; Thomsen et al., 1994) and the
tegument binding to the capsid (Chen et al., 2001), it affected the
capsid stability (Thomsen et al., 1994). On the other hand, though
the HCMV SCP had no role in capsid assembly, it inﬂuenced the
tegument attachment to the capsid (Borst et al., 2001). Contrary to
these ﬁndings was the observation that the KSHV SCP was
indispensable for the viral capsid assembly, though this was
documented only in a heterologous transient baculovirus based
insect cell culture system (Perkins et al., 2008).
Based on the protein interaction patterns of ORF65 and the
plausibility that the SCP could be uniquely adapted to serve
different functions across the different herpesviral groups, it
becomes essential to decipher the functional role of ORF65 in a
genuine system capable of supporting a normal KSHV lytic life-cycle
with the entire KSHV lytic repertoire also coming into play. For this
purpose, we generated ORF65-null recombinant mutants, with the
bacterial artiﬁcial chromosome (BAC) and genetic recombineering
technology. Our study ﬁndings revealed that both a deletion of
ORF65 from the KSHV genome as well as an elimination of its
synthesis resulted in noticeable decreases in yield of progeny
viruses and was attributed to an absence in the synthesis of
functional KSHV capsids.Results
Interaction patterns of KSHV capsid proteins
In related herpesviruses including HSV-1 and HCMV, dynamic
interactions amongst the viral capsid proteins have been well studied.
Information garnered from these studies has helped to better
understand the capsid assembly pathways. Similar studies in KSHV
in addition to providing insights into KSHV capsid assembly, could
also help in identifying interaction patterns conserved across the
different herpesviral groups as well as those unique to KSHV.
Potential interactions between the KSHV capsid proteins were
investigated by co-immunoprecipitation approaches. The cDNAs of the
different KSHV capsid proteins, (i) ORF25 (MCP), (ii) ORF62 (TRI-1),
(iii) ORF26 (TRI-2), (iv) ORF65 (SCP), (v) ORF17.5 (SCAF),were cloned
into both the pCMV-3Tag-1 (ﬂag) and pCMV-3Tag-2 (myc) expression
vectors. Each of the protein cloned into the myc-tagged vector, were
tested for their abilities to interact with itself andwith the other capsid
components cloned into the ﬂag-tagged vector, through transfection
of the paired vectors into HEK-293T cells. Immunoprecipitation (48 h
post-transfection)with an anti-ﬂag antibody and subsequentWestern
blot analyses with an anti-myc antibody allowed for the identiﬁcation
of potential interactions.
Potential interactions identiﬁed between the different KSHV
capsid components are presented in Table 1. The self-association of
ORF17.5 and its interaction with ORF25 was as expected, with
homologous interactions witnessed in both HSV-1 (Desai and Person,
1996; Zhou et al., 1998) and HCMV (Wood et al., 1997), essential
towards initiation of capsid assembly. Interestingly ORF17.5 also
interacted with both ORF62 and ORF65, not documented in other
herpesviruses. ORF25 being the heaviest of the capsid components
constituting the bulk of the KSHV capsid, on predictable lines
interacted with multiple capsid proteins including the triplexes
(ORFs 26 and 62) and ORF65 (Table 1). The dimeric association of
ORF26 with itself and its interaction with ORF62 (Table 1) was also
not surprising, given that similar interactions also exist between their
homologs in HSV-1 (Newcomb et al., 1993). These are essential
towards formations of the hetero-trimeric complexes that serve to
stabilize the capsid.
In addition to interacting with ORF25 (MCP), ORF65 also
associated with the triplex proteins, ORFs 26 and 62 (Table 1 and
Fig. 1). These interaction patterns of KSHV ORF65, suggested a
probable role for this protein in the capsid assembly processes. The
next part of our study was hence designed to comprehend the speciﬁc
role of KSHV ORF65 in a system capable of supporting a normal lytic
KSHV life-cycle following TPA induction.
Generation of ORF65-null recombinant KSHV
To investigate the functional roles of ORF65 in the KSHV viral life-
cycle, we constructed ORF65-null recombinant mutants. These
included both the BAC-Δ65 (with a deletion of the ORF65 coding
sequence) and the BAC-stop65 (with a premature stop codon inserted
into the ORF65 coding sequence) mutants. Cloning of the KSHV
Fig. 1. Interaction patterns of KSHV capsid protein ORF65 with the viral capsid proteins
by the co-immunoprecipitation approach. Sub-conﬂuent human embryonic kidney
(HEK) 293T cell monolayers were cotransfected with an ORF65 expressing plasmid
(pCMV-ORF65-3Tag2, myc-tagged) and each of the expression vectors of the ﬂag-
tagged (pCMV-3Tag-1) KSHV capsid proteins, ORFs 17.5, 25, 26, 62 and 65. Forty-eight
hours post-transfection, whole cell extracts were prepared from the transfected cells,
and the expression levels of both ORF65 and the respective capsid protein were
detected by a Western blot (WB) employing anti-ﬂag (upper panel) and anti-myc
antibodies (middle panel), respectively. The cell extracts were immunoprecipitated
(IP) with an anti-ﬂag antibody and the immunoprecipitates were resolved on SDS-
PAGE gels and subjected to a Western analysis with an anti-myc antibody to detect the
presence of ORF65 in the pellets (lower panel). The molecular mass standards (in kDa)
are indicated on the left.
308 N. Sathish, Y. Yuan / Virology 407 (2010) 306–318genome as a BAC has greatly facilitated the genetic manipulation of
the former in E. coli. A BAC-cloned KSHV (BAC36) constructed and
reported previously (Zhou et al., 2002), harbors the entire KSHV
genome, and infectious virus particles can be reconstituted from it by
its transfection into 293T cells (Zhou et al., 2002; Zhu et al., 2006).
BAC36 contains both the hygromycin resistance gene and the green
ﬂuorescent protein (GFP) gene markers, allowing for easy selection
anddetection of cells transfectedwith theBAC containedKSHVgenome.
First we constructed the BAC-Δ65 mutant, through replacement of the
ORF65 coding sequence in BAC36 with a Kan/SacB cassette byrecombineering technology (recombination-mediated genetic engi-
neering). Brieﬂy, a bacterial double selection cassette Kan/SacB ﬂanked
by sequenceshomologous to theﬁrst 50-ntbefore the initiation codonof
ORF65 and the ﬁrst 50-nt next to the stop codon of ORF65 at two ends
was synthesized by PCR and transformed into E.coli EL350 cells carrying
BAC36. Induction of recombination activity in the EL350 cells at 42 °C
resulted in the replacement of ORF65 with the Kan/SacB cassette. The
kanamycin resistance gene encoded by the cassette (Kan/SacB) allowed
for selection of BAC-Δ65 transformants on plates containing kanamycin.
DNAs isolated from these transformant colonies were digested with
EcoR1 and analyzed on 0.8% agarose gels. Digestion of the wild-type
BAC36 DNA with EcoR1 generated two fragments of sizes 10.3 and
3.2 kb, at the ORF65 locus (Figs. 2A and B). Replacement of the ORF65
coding sequence with the Kan/SacB cassette resulted in a change in
digestion pattern giving a single fragment of 16 kb (Figs. 2A and B).
Further conﬁrmation by southern blot hybridization (data not shown)
was also performed to verify restriction digestion ﬁndings employing
32P-labeledKan/SacB andORF65coding sequences as sequential probes.
Nucleotide sequencing analysis conﬁrmed the successful replacementof
the ORF65 coding sequence with the Kan/SacB cassette (Fig. 2C). This
recombinant mutant was thus designated the BAC-Δ65.
In the second step, both a revertant (BAC-rev65) and stop-codon
mutant (BAC-stop65) were generated. Towards generation of the
BAC-rev65, a PCR fragment of wild-type ORF65 sequence was
introduced into the BAC-Δ65-bearing EL350 cells. A desired recom-
bination was thus expected to replace the Kan/SacB cassette in the
BAC-Δ65 with a wild-type ORF65 sequence. The SacB of the Kan/SacB
cassette encodes for the Bacillus subtilis levansucrase enzyme, which
converts sucrose to levan, a toxic metabolite that results in bacterial
cell death (Dedonder, 1966). This allows for selection of bacterial
clones with revertant BAC DNA on plates with sucrose, against those
with the BAC-Δ65 DNA that get killed. However we observed growth
of a large number of colonies with undesired recombinations
(presumably due to repeat sequences in the viral genome), a
phenomenon previously noticed in our laboratory (Zhu et al., 2006).
We overcame this problem by performing an in situ colony
hybridization (Grunstein and Hogness, 1975), with an ORF65 coding
sequence as a probe, to identify clones with the expected recombi-
nation. The few clones thus selected were veriﬁed by restriction
enzyme digestion and Southern blot analyses. Clones displaying the
expected patterns were designated as the BAC-rev65.
In a similar manner, a recombinant mutant carrying a premature
stop codon was also generated and desirable clones wherein the Kan/
SacB cassette was replaced with an ORF65 coding sequence (with a
premature stop codon) were identiﬁed and veriﬁed by both
restriction enzyme digestion (Fig. 2B) and Southern blot (data not
shown). Clones which following nucleotide sequencing revealed a
replacement of AGA to TGA (stop codon) at the 7th codon were
designated as the BAC-stop65 mutant (Fig. 2C).
Absence of ORF65 had no signiﬁcant effect on the KSHV gene expression
HEK 293T cells were transfected with the BAC36, BAC-rev65 and
the BAC ORF65-null mutant (BAC-Δ65 and BAC-stop65) DNAs. The
presence of GFP markers in the respective BAC genomes allowed us to
monitor transfection efﬁciencies, while the presence of hygromycin
resistance gene allowed for the enrichment of transfected cells. When
almost 100% of the cells revealed GFP ﬂuorescence, cells were treated
with TPA to induce the viral lytic replication as transfection of the cells
with the BAC genomes by default only results in latency. Whole cell
lysates prepared from both induced and uninduced cells were
analyzed for the expression levels of multiple viral genes by a
Western blot employing speciﬁc antibodies. As expected, ORF65 was
not detected in the cell lysates prepared from 293T cells carrying the
BAC-Δ65 and the BAC-stop65 mutants, but was however detected in
lysates prepared from 293T cells harboring the BAC36 and BAC-rev65
Fig. 2. Construction and analyses of BAC-ORF65-null mutant strains. (A) Schematic representations of the structures of ORF65 in the wild-type (BAC36) and the ORF65-null mutant
BAC (BAC-Δ65 and BAC-stop65) clones. The nucleotide (nt) positions representing the initiation (ATG) and the stop (TGA/TAG) codons of the respective viral ORFs (ORFs 64, 65 and
66) are indicated with the nucleotide sequences referring to GenBank accession number U75698. The “X”mark in the BAC-stop65 clone represents the position of the premature stop
codon in the ORF65 coding sequence. The fragment sizes obtained following EcoR1 digestion of both the BAC36 (wild-type) and the BAC-ORF65-null mutant (BAC-Δ65 and the BAC-
stop65) strains are also shown. (B) Electrophoretic analysis of the ORF65-null mutant viral genomes. BAC36 (wild-type) and the BAC-ORF65-null mutant (BAC-Δ65 and BAC-
ORF65stop) DNAs were digested with EcoR1, resolved on a 0.8% agarose gel and stained with ethidium bromide. The DNA ladder (1 kb–10 kb) that was concomitantly run is shown
on the left side of the gel. (C) Nucleotide sequences of the BAC36 (wild-type) and the BAC-ORF65-null mutant (BAC-Δ65 and the BAC-stop65) DNAs at the ORF65 locus. The initiation
codon of the ORF65 coding sequence in the BAC36 and the stop codon (TGA) at the 7th amino acid in the BAC-stop65 sequences are boxed. The site of the Kan/SacB cassette in the
BAC-Δ65 sequence is also indicated.
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between the wild-type KSHV (BAC36 and BAC-rev65) and the ORF65-
null mutants (BAC-Δ65 and BAC-stop65) with respect to expression
of viral genes of different kinetic categories, including the latency
associated nuclear antigen (LANA), ORF50 (RTA), ORF45, ORF59
(polymerase processivity factor or PPF) and ORF64 (Fig. 3). These
ﬁndings suggested that the absence of ORF65 expression in the
ORF65-null recombinant mutants had no discernible effect on the
expression of latent (LANA), immediate-early (RTA and ORF45),
delayed-early (ORF59) and late (ORF64) viral gene expression.
Viral lytic DNA replication appears not to be affected by ORF65
deﬁciency
Next, we investigated the role of ORF65 in the viral DNA
replication. Stable 293T-BAC wild-type (BAC36 and BAC-rev65) and
293T-BAC-ORF65-null (BAC-Δ65 and BAC-stop65) monolayers were
induced into the lytic cycle through TPA induction and levels of
intracellular viral DNA in these induced cells were estimated by a real-Fig. 3. The absence of ORF65 has no signiﬁcant effect on the expression proﬁles of the
KSHV genes. 293T monolayers stably transduced with the wild-type (BAC36 and BAC-
rev65) and the ORF65-null mutant (BAC-Δ65 and BAC-stop65) DNAs were induced
with TPA for 48 h. Cell lysates prepared from the induced cells were concomitantly run
along with the respective uninduced lysates and subjected to a Western blot to detect
the expression levels of the different KSHV viral proteins of diverse kinetic categories
using speciﬁc antibodies against respective virion proteins. The blot was also reprobed
with an anti-β-actin antibody to ensure equal loading of each sample. The molecular
mass standards (in kDa) are indicated on the left.time PCR as described earlier (Sathish et al., 2009; Zhu et al., 2006). No
noticeable differences in levels of intracellular KSHV genomic copy
number (normalized to GAPDH)was observed between the wild-type
and the ORF65-null mutants (Fig. 4). To ensure the reproducibility of
this phenomenon, a total of 3 clones each of the BAC-Δ65 and BAC-
stop65mutants were tested all of which showed similar results. These
ﬁndings thus suggested that ORF65 does not have a vital role to play in
the KSHV viral lytic DNA replication.
ORF65-null mutants produce signiﬁcantly fewer progeny virions
We were next motivated to investigate if the deﬁciency of ORF65
had any effect on the production of progeny virions. The pooled
hygromycin-resistant and GFP-positive cells were induced with TPA
for 5 days. Viral particles released were collected from the culture
media, passed through 0.45-μm ﬁlters, and concentrated by ultracen-
trifugation over a 25% sucrose cushion. Concentrated viruseswere ﬁrst
treated with Turbo DNase I (Ambion) at 37 °C for 60 min to ensure
removal of any contaminating DNA outside the viral particles. Viral
DNAs were extracted and analyzed by a real-time PCR. Employing a
standard curvewith knownamounts of BAC36DNA, the copy numbers
of viral genomes in the induced media were estimated.
The viral copy numbers obtained with both the BAC36 and the
BAC-rev65 viruses was around 1.5×106/ml (Fig. 5). Interestingly
there was a drastic reduction in the released progeny viral titers
(around 5×104 copies/ml) obtained with both the ORF65-null
mutants (BAC-Δ65 and BAC-stop65) amounting to a 30-fold decrease
compared to titers obtained with the wild-type viruses (Fig. 5). As
described above, to ensure reproducibility of this phenomenon, a total
of 3 clones each of the BAC-Δ65 and BAC-stop65 mutants were tested
in two separate assays, all of which showed similar phenotypes. Thus
taken together, our data indicated a crucial role of ORF65 post-viral
gene expression and DNA replication, possibly involving viral
assembly pathways.
Complementation of ORF65-null mutant transfected 293T monolayers
with ORF65 expression replenishes the progeny viral titers
To conﬁrm the probable role of ORF65 in the KSHV viral assembly
processes, stable 293T-BAC-ORF65-null (BAC-Δ65 and BAC-stop65)
monolayers were transfected with an ORF65 expressing plasmid
(pCMV-3Tag-2-ORF65). Forty-eight hours post-transfection, theFig. 4. Deﬁciency of ORF65 does not affect the KSHV viral lytic DNA replication. Stable
293T monolayers harboring either the wild-type BAC (BAC36 or BAC-rev65) or the
ORF65-null mutant BACs (BAC-Δ65 and BAC-stop65) were induced with TPA for up to
48 h. Post-induction, DNAs were extracted from the cells and subjected to a real-time
PCR employing primers directed against the viral ORF73. The viral genome copy
numbers were estimated from a standard curve constructed from serial dilutions of a
known amount of BAC36 DNA. These viral copy numbers were then normalized to
20,000 copies of GAPDH (internal control) and represented as intracellular KSHV
genome copy number. The error bars represent the standard deviations. To ensure
reproducibility of the observation, a total of 3 clones (C1, C2 and C3) each of the BAC-
Δ65 and BAC-stop65 mutants were tested.
Fig. 5. ORF65-null mutants produce signiﬁcantly fewer progeny virions and complementation with ORF65 expression replenishes the progeny viral titers. Stable 293T monolayers
harboring either the wild-type (BAC36 or BAC-rev65) or the ORF65-null mutant BACs (BAC-Δ65 and BAC-stop65) were induced with TPA. Five days post-induction, the released
extracellular KSHV virions were harvested and concentrated 100-fold. Virus stocks were treated with Turbo DNaseI, and viral genomic DNA was extracted. KSHV genomic DNA was
detected by real-time PCR employing primers against the viral ORF73 and quantiﬁed from a standard curve constructed from serial dilutions of a known amount of BAC36 DNA
(external standards). Viral titers are presented as extracellular KSHV genome copies per milliliter (ml) of the supernatant. In a complementation assay, stable 293T-ORF65-null
mutant (BAC-Δ65 and BAC-stop65) monolayers were transfected with an ORF65 expressing plasmid (pCMV-ORF65-3tag-2; myc-tagged) for 48 h. Post-transfection, these
monolayers were induced with TPA for 5 days and the released progeny viral titers were estimated by a real-time PCR as above. The viral titers obtained from such ORF65
complemented monolayers (BAC-Δ65 and BAC-stop65) are indicated in grey bars.
Fig. 6. Role of ORF65 in KSHV viral particle assembly. Stable 293T monolayers harboring
either the wild-type (BAC36 and BAC-rev65) or the ORF65-null recombinant (BAC-Δ65
and BAC-stop65) BACs were induced with TPA. Seventy-two hours post-induction, the
whole cell extracts (WCE) from the BAC36 (lane 1), BAC-rev65 (lane2), BAC-Δ65 (lane
3) and BAC-stop65 (lane 4) monolayers were immunoprecipitated (IP) with an
antibody to the KSHV capsid protein, ORF62 (lanes 6, 8, 10 and 12). The
immunoprecipitates were subsequently analyzed by immunoblotting against the
viral capsid (ORFs 62, 65, 25 and 17.5) and the tegument (ORFs 33, 45 and 64) proteins.
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post-induction and viral titers estimated by a real-time PCR as above.
Ectopically expressed ORF65 (data not shown) in the 293T-BACΔ65
and the 293T-BAC-stop65 monolayer cells was able to successfully
complement the defect in viral assembly processes evidenced by an
increase in the extracellular viral titer levels, to around 1.5×106/ml,
almost comparable to that obtained with the wild-type (BAC36 and
BAC-rev65) (Fig. 5). This experiment thus clearly suggested that
ORF65 does play pivotal roles in the viral assembly processes and that
deﬁciency of this gene in KSHV results in defective progeny viral
release.
Role of ORF65 in viral particle assembly
Next we were motivated to delineate the speciﬁc role of ORF65 in
the viral assembly pathway. Towards this, cell lysates obtained 72 h
post-induction of 293T-BACwild-type (wt) (BAC36 and BAC-rev65)
and 293T-BAC-ORF65-null (BAC-Δ65 and BAC-stop65) monolayers
were immunoprecipitated with an antibody to one of the viral capsid
protein, ORF62. Analysis of immunoprecipitates obtained with the
293T-BACwt (BAC36 and BAC-rev65) monolayers revealed the co-
precipitation of the viral capsid proteins (ORFs 17.5, 25 and 65) and
the viral tegument proteins (ORFs 33, 45 and 64) along with ORF62
(Fig. 6, Lanes 6 and 8).
The immunoprecipitates from 293T-BAC-ORF65-null mutant
(BAC-Δ65 and BAC-stop65) transfected monolayers revealed the co-
precipitation of only the viral capsid proteins, ORFs 17.5 and 25 (Fig. 6,
Lanes 10 and 12). The absence of ORF65 in the complex was expected
but the presence of ORFs 17.5 and 25 co-precipitating with ORF62,
could just be indicative of the interactions between these proteins
occurring as part of the viral capsid assembly, despite absence of
ORF65. However an interesting observation was the failure of the viral
tegument proteins (ORFs 33, 45, 64) to co-precipitate with ORF62
(Fig. 6, Lanes 10 and 12), though their expression was detectable in
the whole cell lysates (Fig. 6, Lanes 3 and 4). This could either be
indicative of the total absence of capsid complex formation itself or
the failure of the tegument proteins to attach to the newly
synthesized capsids exiting out of the nucleus in the absence of
ORF65.
The absence of ORF65 results in failure of nucleocapsid assembly and
nuclear egress
Our next step was thus to investigate as to which of the
possibilities mentioned earlier could have contributed to defective
312 N. Sathish, Y. Yuan / Virology 407 (2010) 306–318KSHV particle release towards which we employed a combination of
approaches. In the ﬁrst approach, we transfected 293T-BAC36 and the
293T-BAC-stop65 stable monolayers with both ﬂag-tagged and myc-
tagged ORF62 expressing vectors. Forty-eight post-transfection,
monolayers were induced with TPA for up to 72 h and the respective
cell lysates obtained were immunoprecipitated with an anti-ﬂag
antibody. A subsequent Western blot with an anti-ﬂag antibody thus
revealed the presence of ﬂag-tagged ORF62 protein in both the BAC36
(Fig. 7, Lane 4) and the BAC-stop65 (Fig. 7, Lane 6) immunoprecipi-
tates. A second Western performed on the immunoprecipitates with
an anti-myc antibody while revealing the presence of co-precipitating
myc-tagged ORF62 in BAC36 (Fig. 7, Lane 4) failed to reveal the same
in BAC-stop65 (Fig. 7, Lane 6). In the absence of self-association of
ORF62 (Table 1), the presence of myc-tagged ORF62 co-precipitating
with ﬂag-tagged ORF62 in the BAC36 immunoprecipitates could only
be indicative of their presumable incorporation in equal stochiometric
amounts into newly assembled capsids. Thus interestingly the
absence of the above observation in the BAC-stop65 immunopreci-
pitates suggests the absence of capsid complex formation with
concomitant deﬁciency of ORF65.
Further reliable evidence on the pivotal role of ORF65 in KSHV
capsid assembly came from a biochemical approach based on
velocity sedimentation. Cell lysates obtained 72 h post-induction of
the 293-BAC36 and 293-BAC-stop65 monolayers were sedimented
through sucrose gradients (20–50%). A total of 20 fractions were
collected from the top to the bottom. Each of the fractions were
resolved on SDS-PAGE gels and subjected to a Western analysis to
detect the presence of the KSHV capsid proteins (ORFs 17.5, 25, 62
and 65). Earlier studies employing velocity sedimentation
approaches to investigate the architecture and the morphological
types of KSHV capsids obtained from lytically induced BCBL-1 cells,
have documented the occurrence of 3 different capsid types,
designated A, B and C, similar to HSV-1 (Deng et al., 2008; Nealon
et al., 2001; Trus et al., 2001). During capsid assembly processes, theFig. 7. Essentiality of ORF65 towards viral capsid assembly. The 293T-BAC36 and 293T-
BAC-stop65 stable monolayers were transfected with both ﬂag (pCMV-ORF62-3Tag-1)-
andmyc(pCMV-ORF62-3Tag-2)-taggedORF62expressionvectors. Forty-eight hours post-
transfection,monolayers were inducedwith TPA for 72 h.Whole cell extracts (WCE) from
both the BAC36 (lane 1) and BAC-stop65 (lane 2) were immunoprecipitated (IP) with
mouse IgG (lanes 3 and 5) or anti-ﬂag antibody (lanes 4 and 6). The immunoprecipitates
were then subjected to aWestern blot (WB)with both anti-ﬂag and anti-mycantibodies to
detect the ﬂag-tagged and the myc-tagged ORF62 proteins, respectively.initially assembled B-capsids, with the ORF17.5 (SCAF) occupying
the inner space, get transformed into the C-capsids, with the
packaged DNA occupying the inner space consequent to exit of SCAF
(Deng et al., 2008; Nealon et al., 2001). The A-capsids on the other
hand represent abortive products with neither the DNA nor the
SCAF, believed to be derived from either the loss of DNA from a C-
capsid or from a premature release of SCAF from B-capsids
(Martinez et al., 1996; McNab et al., 1998). Thus it becomes
possible to distinguish the different capsid forms based on their
densities with the C-capsids being the heaviest, the A lightest and B
in between (Nealon et al., 2001) and the presence or absence of
ORF17.5 (SCAF) with B-capsids alone containing SCAF (Deng et al.,
2008; Nealon et al., 2001; Trus et al., 2001).
The sedimentation proﬁles of the 293T-BAC36 cell lysates revealed
(i) the viral capsid proteins, ORFs 25, 62 and 65 being noticed in
identical denser lower fractions (fraction numbers 11–18) (Fig. 8) (ii)
and the viral ORF17.5 (SCAF) which was noticed in fractions 13 and
14, and peaked in fraction 13 (Fig. 8). Thus based on these evidence it
is reasonable to conclude that the lower fractions revealing the viral
proteins, harbored assembled capsid complexes with the morpho-
logical A-, B- and C-capsid forms peaking in the fraction numbers 11,
13, 16/17 respectively (Fig. 8). However such distinct sedimentation
proﬁles were not seen following fractionation of the 293T-BAC-stop65
cell lysates, with the viral capsid proteins predominantly seen only in
the upper fractions (fractions 2–6) (Fig. 8). Occurrence of this
sedimentation proﬁle unlikely represents assembled capsids which
being very heavy tend to sediment only in the lower fractions as seen
with BAC36wt. Thus this approach suggested the absence of capsid
complex formation in the absence of ORF65.
Mature nucleocapsids are known to be transported across the
nuclear membrane (NM) in a two-step process. (i) NucleocapsidsFig. 8. Sedimentation analysis of KSHV capsids. Stable 293T monolayers harboring
either the wild-type (BAC36) or the ORF65-null mutant (BAC-65stop). DNAs were
induced into the lytic phase with TPA. Seventy-two hours post-induction, cell lysates
were sedimented through sucrose gradients (20–50%). Different fractions (from the top
to the bottom) were collected, resolved on SDS-PAGE gels and immunoblotted with
antibodies against the KSHV capsid proteins (ORFs 25, 62, 65 and 17.5).
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through the inner NM into the space between the inner and outer
NMs, the perinuclear space; (ii) enveloped nucleocapsids in the
perinuclear space fuse with the outer NM, thereby releasing de-
enveloped nucleocapsids into the cytoplasm. To conﬁrm that there is
no mature nucleocapsid made in the nucleus in the cells infected with
ORF65-null mutants, we examined if any nucleocapsids are trans-
ported into the cytoplasm by nuclear egress in the cells. Cytoplasmic
and nuclear extracts obtained 72 h post-induction of 293T-BACwt
(BAC36 and BAC-rev65) and 293T-BAC-ORF65-null (BAC-Δ65 and
BAC-stop65) monolayers were assessed for the relative purity of both
the fractions. A Western analysis to detect the presence of speciﬁc
proteins, PARP (nuclear) and tubulin (cytoplasmic), revealed the
former only in nuclear (Fig. 9, Lanes 1, 3, 5, 7) and the latter only in
cytoplasmic (Fig. 9, Lanes 2, 4, 6, 8) fractions. The levels of expression
of the capsid proteins tested (ORFs 25, 62 and 65) were more or less
comparable in both the nuclear and cytoplasmic extracts obtained
with the 293T-BACwt monolayer cells (Fig. 9, Lanes 1–4) suggesting
the nuclear to cytoplasmic egress of newly synthesized capsids.
However, the levels of expression of the capsid proteins (ORFs 25 and
62) obtained with the 293T-BAC-ORF65-null (BAC-Δ65 and BAC-
stop65) monolayer lysates were noticeably higher in the nuclear
extracts (Fig. 9, Lanes 5 and 7), compared to near negligible levels in
cytoplasmic extracts (Fig. 9, Lanes 6 and 8). Given that capsidFig. 9. Absence of ORF65 results in failures in nucleocapsid assembly and nuclear egress.
Stable 293T monolayers harboring either the wild-type (BAC36 and BAC-rev65) or the
ORF65-null recombinant (BAC-Δ65 and BAC-stop65) BAC DNAs were induced with TPA
for 72 h. Induced monolayers were washed with cold PBS, resuspended in hypotonic
lysis buffer and centrifuged. The resulting supernatant was collected as the cytoplasmic
(C) extract whilst the pellets were washed with hypotonic lysis buffer, resuspended in
whole cell lysis buffer and clariﬁed by high-speed centrifugation to obtain the nuclear
(N) extracts. These extracts were resolved by SDS-PAGE electrophoresis and
immunoblotted with antibodies against the different KSHV capsid proteins (ORFs 25,
62 and 65). The blots were also probed to detect PARP and β-tubulin as the nuclear and
cytoplasmic markers, respectively.assembly occurs in the nucleus subsequent to the cytoplasmic to
nuclear localization of the viral capsid proteins (Rixon, 1993), the
barely detectable levels of ORF25 and ORF62 in the cytoplasmic
extracts is suggestive of the absence of mature nucleocapsid assembly
in the nucleus resulting in a failure towards cytoplasmic egress. Taken
together, our ﬁndings do reliably point to a crucial role of ORF65 in the
KSHV viral capsid assembly.
Discussion
A majority of studies investigating capsid architecture and its
assembly pathways have been conducted in related herpesviruses,
including HSV-1 and HCMV (Beaudet-Miller et al., 1996; Desai and
Person, 1996; Newcomb et al., 1996; Rixon, 1993; Steven and Spear,
1997; Thomsen et al., 1995). Following identiﬁcation of the capsid
proteins in these viruses, pioneering studies have employed compre-
hensive approaches to analyze the interactions amongst these
proteins (Beaudet-Miller et al., 1996; Desai and Person, 1996; Hong
et al., 1996; Lai and Britt, 2003; Lee et al., 2008; Rixon et al., 1996; Saad
et al., 1999; Zhou et al., 1998). These interaction studies have led to
the construction of a capsid protein interaction map helping to
understand the herpesviral capsid assembly pathways. Though few of
the interactions between the KSHV capsid components have been
extrapolated from related studies on HSV-1 and HCMV, a systematic
approach analyzing it has not been undertaken.
In the present study, such an approach was undertaken to analyze
the protein–protein interactions amongst the KSHV capsid proteins.
This led us to identify several interaction patterns, the majority of
which corroborated with those of HSV-1 and HCMV. These included
the self-interaction patterns of the KSHV ORF17.5 (SCAF) well
reﬂected in both HSV-1 (Desai and Person, 1996; Pelletier et al.,
1997; Zhou et al., 1998) and HCMV (Wood et al., 1997), wherein the
homo-dimerization of SCAF mediated through its C-terminal domain
leads to its more efﬁcient binding to MCP in the initial stages of capsid
assembly (Desai et al., 1994; Zhou et al., 1998). Homologous
interactions to that seen occurring between the KSHV ORF17.5 and
ORF25, has also been documentedwith both HSV-1 (Desai et al., 1994;
Desai and Person, 1996; Hong et al., 1996; Rixon et al., 1996; Thomsen
et al., 1995) and HCMV (Beaudet-Miller et al., 1996; Lai and Britt,
2003; Wood et al., 1997). In these viruses, such interactions not only
promote the nuclear translocation of MCP to sites of capsid assembly
but also help to maintain the proper capsid curvature and size during
initial assembly (Desai et al., 1994; Saad et al., 1999; Zhou et al., 1998).
Novel interactions included the association of KSHV ORF17.5 with
both ORF62 (TRI-1) and with ORF65 (SCP), though cross-linking
experiments have revealed complexes between the HSV-1 ORF62
homolog (VP19C) and the SCAF, possibly indicative of capsid
assembly intermediates (Desai et al., 1994).
It was not surprising to see ORF25 interacting with a majority of
the capsid proteins, given that it is the single largest contributor to the
overall mass of the KSHV capsid shell (Nealon et al., 2001). Direct
evidence of homologous interactions to that occurring between KSHV
ORF25 and ORF62, have not been documented in other herpesviruses,
though it has been suggested that such an interaction is very crucial
towards formation of the HSV-1 capsid ﬂoor (Saad et al., 1999). The
interaction of ORF25 with ORF65, reﬂects ﬁndings in other herpes-
viruses, with the nuclear translocation of the SCP being mediated
solely by virtue of its association with the MCP (Desai and Person,
1996; Rixon et al., 1996).
The association of ORF65 with the triplex proteins is well reﬂected
by homologous interactions recently described in HSV-1 (Lee et al.,
2008). It is hence tempting to speculate that the association of ORF65
with the triplexes might accentuate the capsid stabilization function
of the triplexes. Though the KSHV capsid protein interactions reveal
an interesting pattern, caution needs to be exercised in interpreting
these ﬁndings in the context of the viral life-cycle. Potential
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simultaneously expressed in a heterologous cell system wherein the
inﬂuence of the normal/entire KSHV viral lytic repertoire is totally
absent. In spite of these limitations, a majority of the studies
examining herpesviral protein interactions including a previous
study from our laboratory (Rozen et al., 2008) have adopted in-vitro
based approaches like Co-IP and yeast two hybrid (Y2H) in an artiﬁcial
setting. These approaches have become the mainstay for gaining
valuable insights into the viral particle assembly pathways.
Our study ﬁndings on the interaction patterns of ORF65 motivated
us to prove the genuine role of this protein in a system capable of
supporting a normal lytic KSHV life-cycle. Towards investigating the
functional role of ORF65, we constructed 2 ORF65-null recombinant
mutants, a deletion mutant (BAC-Δ65) and a stop mutant (BAC-
stop65). Using the ORF65-null mutants, we undertook a systematic
step-by-step analysis to characterize the stage in the KSHV viral life-
cycle critically mediated by ORF65. Following induction into the viral
lytic phase, levels of both intracellular viral DNA replication and viral
gene expression (of different kinetics from immediate-early to
delayed-early to late) obtained with the ORF65-null recombinant
mutants were very much comparable to levels obtained with the
wild-type (BAC36). However, the ORF65-null mutants released
drastically reduced (amounting to a 30-fold reduction) levels of
progeny virions into the supernatant medium compared to BAC36
with levels being replenished through the extraneous expression of
ORF65 in the former. This clearly indicated a vital role of ORF65 in
stages subsequent to viral DNA replication and viral gene expression
but prior to viral egress.
Though capsid assembly and subsequent tegument attachment
proceeded normally with the BAC-wild-type viruses (BAC36 and BAC-
rev65), tegument proteins were totally absent in immunoprecipitated
complexes obtained from the 293T-BAC-ORF65-null monolayer
lysates following immunoprecipitation with an anti-ORF62 antibody.
We hypothesized that deﬁciency of ORF65 could either result in a total
defect in the capsid assembly itself or a possible failure in the
tegument attachment onto assembled capsids. In fact the defective
viral progeny release noticed with SCP deﬁcient HCMV mutants was
attributed to impairment in tegument attachment to pre-assembled
HCMV capsids (Borst et al., 2001), a possibility given that HCMV SCP
was found localized to both pentons and hexons, to which the
tegument proteins are likely to bind. A similar role of KSHV ORF65 in
promoting tegument attachment could be unlikely given that an
earlier study from our laboratory, failed to notice interactions of any of
the tegument proteins with ORF65 (Rozen et al., 2008).
Several important observations allowed us to rationally conclude
that the defective viral progeny release witnessed with the ORF65-
null recombinant mutants, was due to the defective capsid particle
assembly. Sedimentation proﬁles of the viral capsid proteins (ORFs
17.5, 25 and 62) obtained with the BAC36 viruses reﬂecting their
organization into the previously described patterns for the KSHV A-,
B- and C-capsids (Nealon et al., 2001; Trus et al., 2001) was
unnoticeable with the ORF65-null mutants. This suggested the vital
role of ORF65 in the capsid assembly processes. In addition was
another interesting observation, wherein levels of capsid proteins
(ORFs 25 and 62) in the cytoplasmic extracts obtained from induced
ORF65-null recombinant mutants were negligible, compared to their
noticeable levels in nuclear extracts. This suggested that (i) nuclear
translocation of the capsid proteins, an important pre-requisite
towards capsid assembly (Rixon et al., 1996), is not affected by
ORF65, with similar observations alsowitnessed in HSV-1 (Desai et al.,
2003) and (ii) though the presence of these proteins in nuclear
extracts could be indicative of these complexing into a capsid during
the initial stages of capsid assembly, their noticeably low levels in
cytoplasmic extracts illustrated that the capsid assembly does get
defective subsequently failing to release mature capsid complexes
into the cytoplasm.ORF65 was also shown by Perkins et al. (2008) to be essential for
viral capsid synthesis though only in a heterologous and a transient
baculovirus based insect cell culture system wherein the inﬂuence of
the KSHV lytic gamut could not be accounted for. Compared to this
earlier study, our study generated ORF65-null recombinant mutants
(employing the BAC system and genetic recombineering technology)
to decipher the functional role of ORF65. This system in addition to
being a respectable technical accomplishment, served as a more
direct, reliable and a convincing platform to assess the functional role
of ORF65 employing a set-up capable of supporting a normal lytic
KSHV life-cycle wherein the entire viral lytic repertoire also comes
into play following TPA induction. Thus a step-by-step phenotypic
characterization of the ORF65-null recombinant mutants combined
with biochemical approaches allowed us to zero in on the pivotal role
of ORF65 in the viral capsid formation stage of the KSHV life-cycle.
In conclusion, our study has helped delineate interaction patterns
amongst the KSHV capsid proteins providing valuable insights into
the viral capsid architecture and its assembly pathways. Some of the
novel interaction patterns described in this study either have not been
strong enough to be detected in related alpha and beta herpesviruses,
or could just be serving a supplemental role in augmenting the capsid
assembly in KSHV.
In addition, this study also has suggested a very vital role of ORF65
(SCP) in the KSHV capsid assembly pathways. The functional role of
the KSHV SCP is unique, with SCPs of both HSV-1 and HCMV having no
effect on capsid assembly (Borst et al., 2001; Tatman et al., 1994;
Thomsen et al., 1994), though the HSV-1 SCP affected capsid stability
(Thomsen et al., 1994) while the HCMV SCP affected the tegument
attachment to capsids (Borst et al., 2001). Such distinct functional
roles of the herpesviral SCPs are not surprising given that they are the
least conserved among the different herpesvirus families both in
terms of size and amino acid sequence (Nealon et al., 2001; Trus et al.,
2001; Wingﬁeld et al., 1997; Wu et al., 2000), with a mere 6% identity
between the SCP sequences of KSHV and HSV-1 (Trus et al., 2001).
Interestingly the SCPs share signiﬁcant sequence homology across
members of the gammaherpesviruses, hence could be poised to play
similar roles in capsid assembly as seen with KSHV (Lin et al., 1997).
Thus this study helps to add one more vital function to ORF65 in
addition to its role as an important immunological marker in KSHV
infection (Simpson et al., 1996; Tedeschi et al., 2002). Based on its
important functional role in viral capsid assembly, ORF65 inhibition
could well be evaluated as a potential anti-viral strategy in KSHV
associated infections.
Materials and methods
Cells and Escherichia coli strains
Human embryonic kidney (HEK) 293T cells obtained from ATCC
were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM). BCBL-
1 cells, a primary effusion lymphoma cell line latently infected with
KSHV, were obtained from NIH AIDS Research and Reference Reagent
Program and was cultured in RPMI 1640 medium. All cultures were
supplemented with 10% heat-inactivated fetal bovine serum (FBS)
and antibiotics. E.coli strain EL350 was obtained from Neal Copeland
and Nancy Jenkins (Lee et al., 2001). BAC36, which carries the entire
KSHV genome has been described earlier (Zhou et al., 2002) and was
provided by Dr. S. J. Gao at the University of Texas at San Antonio.
Capsid protein interaction studies
To investigate the interactions amongst the KSHV virion capsid
proteins, the cDNAs of the different viral capsid proteins: (i) ORF17.5
(Scaffold), (ii) ORF25 (MCP), (iii) ORF26 (TRI-2), (iv) ORF62 (TRI-1),
(v) ORF65 (SCP), were ampliﬁed by PCR employing speciﬁc primers
(Table 2). PCR ampliﬁed products were subsequently cloned into the
Table 2
Primers used for construction of KSHV capsid protein expression vectors.
KSHV ORF Primer sequences
ORF17.5/F 5′-CGCGGATCCATGAACAGCTCTGGTCAAGAG-3′










(i) F and R denote the forward and the reverse primer sequences respectively.
(ii) The restriction sites in both the forward and the reverse primers are italicized and
the translation initiation sequence is represented in bold case in the forward primers.
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either a three-Flag tag (pCMV-3Tag-1) or a three-myc tag (pCMV-
3Tag-2). Individual capsid proteins cloned into the pCMV-3Tag-2
vector was tested for its interaction capabilities with itself and with
the other capsid proteins cloned into the pCMV-3Tag-1vector, by co-
transfection of the plasmid DNAs (10 μg each) into HEK 293T cells
grown in 100-mm dishes. Transfection was performed with the
calcium phosphate transfection method. At 48 h post-transfection,
cells were washed twice with 1× PBS and lysed with ice-cold lysis
buffer (50 mM Tris–HCl [Ph7.4], 150 mM NaCl, 30 mM NaF, 5 mM
EDTA, 10% glycerol, 40 mM α-glycerophosphate, 1 mM phenyl-
methylsulfonyl ﬂuoride [PMSF], 1% Nonidet P-40, 1 mM sodium
orthovanadate) supplemented with protease inhibitor cocktail
(Roche).
The cell lysates were homogenized and clariﬁed by high-speed
centrifugation at 4 °C and subsequently tested for the expression of
the respective protein pairs by Western blotting, employing the
appropriate antibodies (anti-ﬂag and anti-myc). Following successful
expression of both the transfected proteins, immunoprecipitation was
performed by incubating the cell lysates with an anti-Flag M2 Afﬁnity
gel (Sigma) for 2 h at 4 °C. Immunoprecipitated complexes were then
washed with the lysis buffer ﬁve times, following which they were
resuspended in 100 μl of sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer and boiled for 10 min.
Complexes were separated on SDS-PAGE 8–12% bis–Tris gels
(Invitrogen) and transferred to nitrocellulose membranes. Mem-
branes were blocked in 5% dried milk in 1× PBS with 0.2% Tween 20
and incubated ﬁrst with a mouse monoclonal anti-myc antibody and
then with an anti-mouse immunoglobulin G antibody conjugated to
horseradish peroxidase (Pierce). An enhanced chemiluminescence-
based system (SuperSignal West Dura extended duration substrate;
Pierce) was employed for detection of the interacting protein pairs.
Genetic manipulation of KSHV BAC genome
Mutagenesis of BAC36 to generate the BAC-ORF65-null recombi-
nant mutants was performed by employing a recombineering systemTable 3
Primer sequences employed for the construction of the BAC-Δ65, BAC-rev65 and BAC-stop





ORF65stop-5′ 5′-TGTTGCGGGAAGTGTTCCTCCTGAGGCTATTTCGC(http://www.recombineering.ncifcrf.gov). BAC36 was ﬁrst intro-
duced into EL350 by electroporation. The EL350 strain contains a
defective prophage that harbors the recombination genes exo, beta,
and gam under the tight control of a temperature-sensitive c1857
repressor. In such a system, recombination gets accomplished by the
transient shift of cultures to 42 °C for 15 min (Lee et al., 2001). To
generate an ORF65 deletion mutant, the ORF65 coding sequence of
BAC36 was replaced with a kanamycin [(Kan)/SacB] cassette
through homologous recombination. The Kan/SacB cassette was
ampliﬁed from the plasmid pBS-Kan/SacB with the ORF65-Kan/
SacB-5′ (forward) and the ORF65-Kan/SacB-3′ (reverse) primers
(Table 3). Each primer contains 21 nucleotides (nt) homologous to
the antibiotic resistance cassette Kan/SacB at its 3′ end (represented
in lower case) and 50 nt homologous to the ﬁrst 50 nt immediately
before the start and after the stop codons of ORF65 respectively at
the 5′ end (represented as capital letters). Employing these primers,
the Kan/SacB cassette (which contains both the kanamycin
resistance encoding gene and SacB) was ampliﬁed by a PCR
performed at 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 2 min for
30 cycles with the Roche Expand high-ﬁdelity Taq polymerase. The
PCR product was treated with DpnI to ensure removal of the plasmid
template. The digested product was gel puriﬁed with the QIAquick
gel extraction kit (Qiagen) and 200 ng of this was subsequently
electroporated into BAC36-containing EL350 cells pre-induced at
42 °C for 15 min. Electroporation was performed at 1.75 kV, 276Ώ,
and 50 μF in a 0.1-mm cuvette (BTX). The recombinant clones were
selected at 32 °C on LB plates containing chloramphenicol (12.5 μg/
ml) and kanamycin (50 μg/ml) and characterized by restriction
enzyme digestion and southern blot analyses. The resultant BAC was
designated BAC-Δ65.
The next step was to generate a revertant mutant and a mutant
containing a premature stop codon in the ORF65 coding sequence. For
generation of the revertant mutant, the Kan/SacB cassette in BAC-Δ65
was replaced with a wild-type ORF65 sequence by homologous
recombination similar to that described above; the wild-type ORF65
sequence was ampliﬁed by PCR, employing the ORF65rev-5′ (for-
ward) and the ORF65rev-3′ (reverse) primers (Table 3). For the stop-
codon mutant, the Kan/SacB cassette in BAC-Δ65 was likewise
replaced with an ORF65 sequence (harboring a premature stop
codon) generated by a PCR employing the ORF65stop-5′ (forward)
and the ORF65rev-3′ (reverse) primers (Table 3). The lower case
letters “tga” in the forward primer sequence, represents a single point
mutation introduced at the seventh amino acid of ORF65 substituting
a “A” for a “t”, resulting in the replacement of the 7th “AGA” codon
(that encodes for arginine) to a “tga” that encodes for a stop codon.
Towards generating both the revertant and the stop-codonmutant
viruses, 200 ng of the respective gel-puriﬁed PCR fragments was
electroporated into EL350 cells carrying BAC-Δ65. Transformants
were selected at 32 °C on LB plates containing chloramphenicol
(12.5 μg/ml) with 7% sucrose. Presumably as a result of repetitive
sequences in the viral genome many sucrose-resistant colonies grew,
with a vast majority of them harboring unexpected recombinations
(Zhu et al., 2006). Thus to identify the few clones that possessed the
expected recombination, an in situ colony hybridization was
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identiﬁed were expanded, the respective BAC DNAs extracted and
analyzed by restriction enzyme digestion, southern blotting and
sequencing analyses. Respective BAC DNAs (BAC-rev65 and BAC-
stop65) thus conﬁrmed to have the proper recombinations were
prepared from large-scale overnight cultures with a large-construct
kit (QIAGEN).
Generation of BAC transfected stable monolayers
Freshly prepared BAC DNAs (BAC36, BAC-Δ65, BAC-rev65, BAC-
stop65) were introduced into 293T cells by transfection. Brieﬂy,
1 μg of the respective BAC DNA was transfected into 293T cells
grown to a 40–60% conﬂuence in a 60-mm dish with the QIAGEN
Effectene transfection kit. Forty-eight hours post-transfection, cells
were examined under a ﬂuorescence microscope and subcultured
into T150 ﬂasks with fresh medium containing 200 μg/ml hygro-
mycin (Roche). When hygromycin-resistant colonies were visible
(10–14 days post-transfection), they were dislodged and seeded
into a new T150 ﬂask. When the monolayer reached 80–90%
conﬂuence, cells from each ﬂask were split into new T150 ﬂasks and
the respective 293T-BAC transfected stable cell monolayers thus
generated were maintained by periodical splitting. Conﬂuent
monolayers were treated with 20 ng/ml TPA for induction into
the viral lytic phase. Cells were harvested 48 h post-induction for
preparation of whole cell lysates or continued for up to 5 days for
collecting the released extracellular virion particles.
Detection of viral protein expression
The respective 293T-BAC transfected and induced/uninduced
monolayer cells were washed twice with PBS and subsequently
lysed with ice-cold lysis buffer (Rozen et al., 2008). Cell lysates were
homogenized, clariﬁed by high-speed centrifugation, resolved on
SDS-PAGE gels and subjected to aWestern blot as earlier to detect the
expression of the different viral proteins using the appropriate
antibodies followed by incubation with either anti-rabbit or anti-
mouse secondary antibodies conjugated to horseradish peroxidase. A
similar chemiluminescence-based system as outlined earlier allowed
for detection of the speciﬁc viral protein.
Preparation of DNA from cells and viral stocks
Towards preparation of intracellular DNA, the respective BAC DNA
transfected monolayers induced for 48 h were trypsinized, washed,
and resuspended in 200 μl of 1× PBS. Subsequently total DNA was
extracted with a DNeasy tissue kit (QIAGEN) following the manu-
facturer's instructions.
For DNA extraction from viral stocks, virions released into the
extracellular medium 5 days post-induction, were puriﬁed and
concentrated from the medium supernatant as described earlier
(Sathish et al., 2009; Zhu et al., 2006). Virion pellets were ﬁnally
dissolved in 1% of the original volume of 1× PBS and stored at−80 °C.
Virus stocks (200 μl) were pretreated with 10 μl of Turbo DNase I
(Ambion) at 37 °C for 60 min to ensure removal of any contaminating
DNA outside viral particles. DNAwas subsequently extracted as earlier
(Sathish et al., 2009) and was ethanol precipitated with glycogen and
the ﬁnal DNA pellet dissolved in 40 μl of Tris–EDTA buffer.
Quantitation of viral genomic DNA
Copy numbers of KSHV genomic DNA in both viral stocks and in
the cellular DNA extracted from induced cells were determined by a
real-time PCR performed in a Roche LightCycler using the LightCycler
FastStart DNA MasterPlus SYBR green kit. Viral DNA copy numbers
were estimated from external standards of known concentrations ofBAC36 DNA employing primers directed against the KSHVORF73 gene
as described earlier (Krishnan et al., 2004). Viral genomic DNA copy
numbers obtained from viral stocks were expressed as copy number/
ml of the medium supernatant, while the intracellular viral copy
numbers were normalized to that of GAPDH.
ORF65 complementation assay
Fifteenmicrograms of an ORF65 expression vector (pCMV-3Tag-2-
ORF65, myc-tagged) was transfected into the 293T-BAC-ORF65-null
recombinant mutant (BAC-Δ65 and BAC-stop65) transfected stable
monolayers with the calcium phosphate protocol. After 48 h, cells
were induced with TPA for 5 days, extracellular virions collected and
quantiﬁed as detailed above.
Co-immunoprecipitation assay
(i) To investigate the functional role of ORF65 in the KSHV viral
particle assembly, the respective 293T-BAC transfected stable mono-
layer cells induced for 72 h were washed twice with 1× PBS and lysed
with ice-cold lysis buffer (Rozen et al., 2008). Cell lysates were
homogenized and clariﬁed by high-speed centrifugation at 4 °C.
Subsequently the cell lysates were immunoprecipitated with an
antibody to the KSHV capsid protein ORF62 for 2 h at room
temperature. Immunoprecipitated complexes were thoroughly
washed with the lysis buffer at least 5 times and were resuspended
in 100 μl of SDS-PAGE loading buffer and boiled for 10 min. Complexes
were then subjected to aWestern blot to detect the presence of ORF62
as well as other co-precipitating capsid (ORFs 17.5, 25 and 65) and
tegument (ORFs 33, 45 and 64) proteins using the appropriate
antibodies. (ii) To investigate the functional role of ORF65 in the KSHV
capsid assembly processes, the 293T-BAC36 and 293T-BAC-stop65
stable monolayers were transfected with both ﬂag (pCMV-ORF62-
3Tag-1) and myc (pCMV-ORF62-3Tag-2)-tagged ORF62 expression
vectors by a calcium-phosphate transfection method. Forty-eight
post-transfection, monolayers were induced with TPA for up to 72 h
and cell lysates prepared as detailed above. Immunoprecipitates were
subsequently obtained by subjecting the respective cell lysates to
immunoprecipitation with the anti-Flag M2 afﬁnity gel (Sigma)
pulling down the ﬂag-tagged ORF62 protein. Co-precipitating myc-
tagged ORF62was detected by subjecting the immunoprecipitates to a
western blot with an anti-myc antibody.
Sedimentation/fractionation analysis
The 293T-BAC36 and the 293T-BAC-stop65 stable monolayers
induced into the lytic phase for 72 h, were harvested in PBS, washed
again with PBS and cell lysates prepared. Lysates were subsequently
layered onto 20–50% sucrose gradients and sedimentation was
performed in a Beckman SW41 rotor at 39,000 rpm for 60 min.
Fractions were sequentially collected from the top of the gradient and
were resolved by SDS-PAGE. Resolved fractions were subjected to a
western blot to detect the presence of the different KSHV capsid
proteins (ORFs 17.5, 25, 62 and 65) using appropriate antibodies.
Preparation of nuclear and cytoplasmic extracts
BAC transfected stable monolayer cells induced for up to 72 hwere
washed with cold PBS, resuspended in hypotonic lysis buffer (10 mM
HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol,
protease inhibitor cocktail) and incubated on ice with gentle mixing
from time to time for 15 min. The lysates were centrifuged at
1500×g for 15 min, and the resulting supernatants were collected
as cytoplasmic extracts. The pellets were washed once with the
hypotonic lysis buffer, resuspended in whole cell lysis buffer (Rozen
et al., 2008), and cleared by high-speed centrifugation to obtain the
317N. Sathish, Y. Yuan / Virology 407 (2010) 306–318nuclear extracts. The protein concentrations of both the nuclear and
cytoplasmic extracts were determined with a bicinchoninic acid
(BCA) protein assay kit (Pierce Biotechnology). About 50 μg of the
respective extracts obtained for each sample was resolved by SDS-
PAGE electrophoresis and the purity of both the nuclear and
cytoplasmic extracts were ﬁrst tested by analyzing levels of PARP
(nuclear) and tubulin (cytoplasmic) proteins by a Western blot
employing the respective antibodies. Subsequently levels of the
different KSHV capsid proteins (ORFs 25, 62 and 65) were tested in
both extracts by Western blotting using the speciﬁc antibodies.
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